中国科学院深圳先进技术研究院脑认知与脑疾病研究所
BCBDI is a Chinese Academy of Sciences neuroscience research institute in Shenzhen operating six brain science centers with 500+ researchers, a Nobel-laureate-led Neher Lab, and proprietary platforms (neurotropic viral tools, BBQSM brain-behavior quantification, LIG-based flexible brain-computer interfaces) that serve 100+ global laboratories via government-funded grants.
- Company typePrivate
- Founded2016
- HeadquartersShenzhen, China
- Headcount11–50
- GTM typeB2B
- OfferingServices
What 中国科学院深圳先进技术研究院脑认知与脑疾病研究所 does
The Brain Cognition and Brain Diseases Institute (BCBDI) is a public neuroscience research institute under the Chinese Academy of Sciences' Shenzhen Institute of Advanced Technology, officially established in 2016 (unveiled in 2014) and headquartered at 1068 Xueyuan Avenue, Shenzhen University Town, Nanshan District. It conducts multi-disciplinary brain research across six centers — Brain Connectome and Behavior, Neurodevelopmental and Neurodegenerative Diseases, Cognitive Science and Intelligence Technology, Translational Research for the Nervous System, the Shenzhen Neher Neural Plasticity Laboratory (directed by 1991 Nobel laureate Erwin Neher), and the Interdisciplinary Center for Brain Information — with a team of 500+ researchers including 65+ national-level talents and international faculty from Stanford, Cambridge, Harvard, UC Berkeley, and Duke.
The institute operates one of the world's most comprehensive neurotropic viral tool libraries (100+ variants including HSV-1, PRV, RV, VSV, AAV, CAV, SFV), serving 100+ global laboratories through a national neural circuit tracing platform. Proprietary platforms include the BBQSM brain-behavior-physiology quantification system, flying-scanning microscopy for micron-resolution whole-brain mapping (Nature Biotechnology 2021), cryo-electron tomography for synaptic ultrastructure (Nature Neuroscience 2020), and laser-induced graphene flexible multimodal brain-computer interfaces (Advanced Functional Materials 2026). Cumulative outputs include ~1,000 high-level SCI publications in Nature, Science, Cell, Neuron, and ~1,300 patent applications with 350+ grants.
BCBDI does not generate revenue from commercial product sales. Its funding model is grant-based: it has secured 950+ national, ministerial, provincial (Guangdong), and municipal (Shenzhen) research projects with cumulative approved funding of approximately 1.9 billion RMB (~USD 280M) since inception. Outputs are disseminated through peer-reviewed publications, international conferences and symposia (including the annual SIAT-Max Planck Symposium and the Neural Circuit Tracing and Regulation Conference), technology transfer and licensing of viral tools and neural interfaces, joint laboratories with industry partners (e.g., Zhaowei Electromechanical, Japan NICT), and academic talent pipelines including the annual "Brain Future" undergraduate summer camp.
中国科学院深圳先进技术研究院脑认知与脑疾病研究所 firmographics
Firmographics- Name
- 中国科学院深圳先进技术研究院脑认知与脑疾病研究所
- Legal name
- 中国科学院深圳先进技术研究院脑认知与脑疾病研究所
- Website
- https://bcbdi.siat.ac.cn
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BCBDI is a Chinese Academy of Sciences neuroscience research institute in Shenzhen operating six brain science centers with 500+ researchers, a Nobel-laureate-led Neher Lab, and proprietary platforms (neurotropic viral tools, BBQSM brain-behavior quantification, LIG-based flexible brain-computer interfaces) that serve 100+ global laboratories via government-funded grants.
- Ownership category
- akta.pro rank
中国科学院深圳先进技术研究院脑认知与脑疾病研究所 industry classification
Industry- Product category
- Neuroscience Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836), Services-Engineering, Accounting, Research, Management (8700)
- akta.pro primary industry
- Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)
- akta.pro secondary industries
- Neurogenetics & Rare Neurologic Diseases (HLAKAIAO), Clinical Research & Trial Central Laboratories (HLAFAMAL), Research Administration & Compliance (Sponsored Programs, IRB/REB) (EDADAKAH)
Keywords
Where 中国科学院深圳先进技术研究院脑认知与脑疾病研究所 is headquartered
LocationHeadquarters
- HQ city
- Shenzhen
- HQ country
- China
- HQ region
- Asia
Offices1 record
Markets served
中国科学院深圳先进技术研究院脑认知与脑疾病研究所 business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations
Revenue model
- Government Research Grants and Project Funding: As a CAS research institute, BCBDI operates primarily through national, ministerial, provincial and municipal research project funding. Has secured over 950 research projects with total approved funding of approximately 1.9 billion RMB (~$280 million USD). Revenue is not derived from commercial product sales.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
中国科学院深圳先进技术研究院脑认知与脑疾病研究所 product offering
Product offeringCore offering
BCBDI conducts multi-disciplinary brain science research across six research centers covering neural circuit mapping, neurodevelopment and neurodegeneration, cognitive science, neural engineering translation, neural plasticity, and brain information processing. The institute operates research platforms providing access to proprietary viral tools, BCI technologies, brain-behavior-physiology quantification systems, and cryo-electron microscopy, while also delivering talent training and academic collaboration services to global neuroscience researchers.
Product overview
The Brain Cognition and Brain Diseases Institute (BCBDI) is a neuroscience research institute, not a commercial product company. It operates six research centers (Centre for Brain Connectome and Behavior, Centre for Neurodevelopmental and Neurodegenerative Diseases, Centre for Cognitive Science and Intelligence Technology, Translational Research Center for the Nervous System, Shenzhen Neher Neural Plasticity Laboratory, and Interdisciplinary Center for Brain Information) that collectively advance brain science research. Key technology offerings include the Neurotropic Viral Tool Library (100+ viral variants for neural circuit research), BBQSM brain-behavior quantification system, Laser-Induced Graphene flexible bioelectronics, cryo-electron tomography, and flying-scanning microscopy. The institute provides research collaboration, talent training, and technical platform access to partner institutions.
Differentiator
Problem solved
Functional benefit
Products and services
- Neurotropic Viral Tool Library A comprehensive library of over 100 neurotropic viral tool variants (HSV-1, PRV, RV, VSV, AAV, CAV, SFV) for structural and functional dissection of neural circuits. Provides viral vector tools for neuroscience research and nervous system disorder diagnosis and treatment.
- BBQSM Brain-Behavior-Physiology Quantification System Proprietary technology system for quantifying brain-behavior-physiology relationships at sub-second temporal precision and fine spatial scales. Enables analysis of behavioral switching characteristics and 'motivation particle' dynamic interactions through synchronous electrophysiology and physiology monitoring.
- Laser-Induced Graphene (LIG) Bioelectronics Flexible multimodal brain-computer interface devices using laser-induced graphene. Enables high-sensitivity physiological sensing and stable long-term neural recording for brain-body interaction studies and closed-loop BCI applications.
- Cryo-Electron Tomography Platform In-situ ultrastructure and molecular architecture analysis of neuronal synapses using cryo-electron tomography. Part of multiscale structural visualization research for membrane proteins including GABA(A) receptors in hippocampal inhibitory synapses.
- Flying-Scanning Microscopy Technology Synchronized flying-scanning microscopy technique achieving micron-resolution imaging and mesoscopic mapping of entire primate brains for whole-brain neural circuit mapping.
- National Neural Circuit Tracing Platform National-level platform providing neural circuit tracing services and viral tool access to research laboratories globally, enabling structural and functional dissection of neural circuits across the central and peripheral nervous systems.
- Flexible Multimodal Brain-Computer Interfaces (f-BCI) Flexible neural electrodes, biosensors, and optogenetic technologies for cell-type-specific modulation across central and peripheral nervous systems. Hydrogel optical fiber electronics with mechanically robust interfaces enable simultaneous electrophysiological recording and optogenetic modulation.
Quantifiable outcome
- Over 950 national, ministerial, provincial and municipal research projects secured; approximately 1.9 billion RMB in total approved funding; approximately 1,000 high-level SCI publications in top-tier journals; nearly 1,300 patent applications filed with over 350 patents granted; neural circuit tracing platform serving 100+ international laboratories
Companies that use 中国科学院深圳先进技术研究院脑认知与脑疾病研究所
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles2 records
中国科学院深圳先进技术研究院脑认知与脑疾病研究所 technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature6 records
中国科学院深圳先进技术研究院脑认知与脑疾病研究所 partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered major, core and minor.
- Chinese Association for Drug Abuse Prevention and Control - Addiction Brain Science Research Professional CommitteemajorHosting the 2026 Academic Annual Conference (August 12-14, 2026) of the Addiction Brain Science Research Professional Committee, co-organized with Shenzhen Kangning Hospital and Shenzhen Key Laboratory of Drug Addiction. Focus on addiction neuroscience mechanisms, diagnosis, intervention and treatment.
- Max Planck Society (MPG), Germanycore2026 SIAT-Max Planck Society Brain Science and Mental Health Cross-Disciplinary Symposium (August 10-11, 2026) jointly organized by SIAT BCBDI and the Max Planck Society. Nobel laureate participation. Focus on neural circuits, molecular mechanisms, and translational psychiatry. Aims to establish a long-term interdisciplinary exchange platform between brain science and mental health researchers from China and Germany.
- National Institute of ElectroCommunications, JapancoreJoint International Laboratory for 'Human-Machine Intelligence Interaction and Functional Rehabilitation' established at SIAT. Co-built by SIAT's Center for Neural Engineering and Japan's National Institute of ElectroCommunications. Collaboration areas include personalized intelligent prosthetics, autonomous rehabilitation wearable devices, robot technology for aging society, and brain-computer interfaces with multi-source information fusion decoding. Agreement signed on September 25, 2024; officially inaugurated on March 10, 2025.
- Zhaowei Electromechanical Co., Ltd. (兆威机电股份有限公司)majorJoint laboratory for 'Dexterous Hand Intelligent System' (灵巧手智能系统联合实验室) established between SIAT and Zhaowei Electromechanical. Focus on dexterous hand technology for surgical robots and humanoid robots. Signed on September 12, 2024. BCBDI provides expertise in sensing, control, and AI; Zhaowei contributes precision manufacturing capabilities.
- Hong Kong University of Science and Technology (HKUST)coreLong-standing research collaboration and talent cultivation partnership. BCBDI spearheads the development of Shenzhen-Hong Kong Institute of Brain Science (深港脑科学创新研究院), a key Shenzhen-based platform. Joint laboratories established for collaborative neuroscience research.
- University of British Columbia (UBC), CanadamajorInternational collaboration in neuroscience research and talent training with UBC, one of Canada's leading research universities.
- INRA (Institut National de la Recherche Agronomique), FrancemajorInternational research collaboration and talent training partnership with INRA France in neuroscience and related fields.
- Humboldt University of Berlin (HU Berlin), GermanymajorInternational research and talent training collaboration with Humboldt University of Berlin (德国洪堡大学).
- Massachusetts Institute of Technology (MIT), United StatescoreInternational collaboration in brain science research and talent cultivation with MIT, USA.
- Shenzhen University of Science and Technology (深圳理工大学)majorOngoing collaborative research with Shenzhen University of Science and Technology (深理工) on neuroscience research including addiction, depression, and brain development mechanisms. Multiple joint research papers co-authored between BCBDI researchers and SUSTech faculty.
- Belt and Road International Science Organization AllianceminorPlanning international scientific cooperation under the Belt and Road International Science Organization Alliance framework. One Belt One Road agricultural disaster remote sensing monitoring and smart agriculture international training program co-organized by SIAT.
Scale indicators6 records
Recent moves9 records
Expansion highlights6 records
中国科学院深圳先进技术研究院脑认知与脑疾病研究所 competitors and assessment
Company assessmentDirect peers
- Janelia Research Campus (HHMI): HHMI's research campus developing imaging technologies, computational neuroscience, and genetic tools for circuit-level brain research. Comparable in its focus on tool development (e.g., fly/mouse brain mapping), viral vectors, and high-throughput microscopy.
- Max Planck Institute for Brain Research: German basic-research institute studying neural circuits, computation, and brain disease. Directly comparable as a publicly funded brain science institute with circuit-tracing, disease modeling and translational outputs, and a current collaboration partner of BCBDI via the SIAT-Max Planck Symposium.
- Allen Institute for Brain Science: Non-profit neuroscience research institute focused on brain mapping, cell types, and large-scale imaging/atlas resources. Directly comparable to BCBDI in mission (open brain science platforms), publication volume, and use of viral/Imaging tool platforms.
- Chinese Institute for Brain Research, Beijing (CIBR): Beijing-based brain science institute backed by the City of Beijing and CASS, focused on circuits, cognition and brain disease. Directly comparable as a Chinese peer institute competing for similar national talent programs, grant pools, and disease-translational milestones.
- RIKEN Center for Brain Science: Japan's national brain science research center under RIKEN, focused on neural circuits, brain development and disease, with strong BCI and imaging programs. Comparable as an Asian publicly funded institute pursuing similar circuit-mapping and disease-translation goals.
- Tsinghua-IDG/McGovern Institute for Brain Research: Joint Tsinghua-IDG/McGovern Institute at Tsinghua University (Beijing) doing neuroscience and BCI research. Highly comparable in scale, talent strategy (returnee PIs), disease focus (Alzheimer's, autism, depression) and translational ambitions.
- Zuckerman Mind Brain Behavior Institute (Columbia): Columbia University's neuroscience institute studying circuits, behavior and brain disease. Comparable in disease focus (Alzheimer's, autism, depression), imaging and circuit-level methodology, and publication impact.
- Champalimaud Foundation - Champalimaud Research: Portuguese neuroscience and cancer research center focused on circuits, behavior, vision and clinical translation. Comparable in combining circuit-level basic research with translational ambitions and international talent.
Broad incumbents
- Salk Institute for Biological Studies: Large, well-established basic-research institute covering neuroscience, genetics, plant biology and immunology. Comparable in research-output scale and Nobel-affiliated faculty, but broader in scope than BCBDI's brain-focused mission.
Emerging players
- Westlake University School of Life Sciences: Newly established Hangzhou-based research university with growing neuroscience and BCI programs. Comparable as a Chinese non-CAS basic-research competitor recruiting returnee PIs and competing for similar talent-program funding.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
中国科学院深圳先进技术研究院脑认知与脑疾病研究所 social profiles
Digital presence中国科学院深圳先进技术研究院脑认知与脑疾病研究所 financial estimates
Financial estimateRevenue estimate
Valuation estimate
中国科学院深圳先进技术研究院脑认知与脑疾病研究所 leadership team
Management profileNumber of profiles
Profiles22 records
中国科学院深圳先进技术研究院脑认知与脑疾病研究所 funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
中国科学院深圳先进技术研究院脑认知与脑疾病研究所 M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 中国科学院深圳先进技术研究院脑认知与脑疾病研究所
What does 中国科学院深圳先进技术研究院脑认知与脑疾病研究所 do?
BCBDI conducts multi-disciplinary brain science research across six research centers covering neural circuit mapping, neurodevelopment and neurodegeneration, cognitive science, neural engineering translation, neural plasticity, and brain information processing. The institute operates research platforms providing access to proprietary viral tools, BCI technologies, brain-behavior-physiology quantification systems, and cryo-electron microscopy, while also delivering talent training and academic collaboration services to global neuroscience researchers.
Is 中国科学院深圳先进技术研究院脑认知与脑疾病研究所 a public or private company?
中国科学院深圳先进技术研究院脑认知与脑疾病研究所 is a private company. It is classified as state government owned and is currently operating.
When was 中国科学院深圳先进技术研究院脑认知与脑疾病研究所 founded?
中国科学院深圳先进技术研究院脑认知与脑疾病研究所 was founded in 2016. It employs 11 to 50 people.
Where is 中国科学院深圳先进技术研究院脑认知与脑疾病研究所 based?
中国科学院深圳先进技术研究院脑认知与脑疾病研究所 is headquartered in Shenzhen, China, in the Asia region.
How does 中国科学院深圳先进技术研究院脑认知与脑疾病研究所 make money?
One revenue line is on record: government Research Grants and Project Funding.
Who are 中国科学院深圳先进技术研究院脑认知与脑疾病研究所's main competitors?
Direct peers on record are Janelia Research Campus (HHMI), Max Planck Institute for Brain Research, Allen Institute for Brain Science, Chinese Institute for Brain Research, Beijing (CIBR), RIKEN Center for Brain Science, Tsinghua-IDG/McGovern Institute for Brain Research, Zuckerman Mind Brain Behavior Institute (Columbia) and Champalimaud Foundation - Champalimaud Research. Salk Institute for Biological Studies is listed as a broad incumbent. Westlake University School of Life Sciences is listed as an emerging player.
Does 中国科学院深圳先进技术研究院脑认知与脑疾病研究所 have an API?
No public API is recorded for 中国科学院深圳先进技术研究院脑认知与脑疾病研究所.
What industry is 中国科学院深圳先进技术研究院脑认知与脑疾病研究所 in?
中国科学院深圳先进技术研究院脑认知与脑疾病研究所's product category is Neuroscience Research Services. Its primary akta.pro industry code is EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based), with a secondary code of HLAKAIAO, Neurogenetics & Rare Neurologic Diseases. Its NAICS code is 541714 and its SIC code is 8731.